Benzinga | Nov 4, 2021 07:22AM EDT

Ironwood Pharmaceuticals Q3 Adj. EPS $0.33 Beats $0.31 Estimate, Sales $103.75M Miss $105.40M Estimate

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.31 by 6.45 percent. This is a 43.48 percent increase over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $103.75 million which missed the analyst consensus estimate of $105.40 million by 1.57 percent. This is a 0.27 percent increase over sales of $103.47 million the same period last year.